(Q37301207)

19 August 2017

1 reference

title

Epigenetic markers in human gliomas: prospects for therapeutic intervention (English)

1 reference

19 August 2017

Luke B Hesson

1

1 reference

PubMed ID

18928342

19 August 2017

Dietmar Krex

series ordinal

2

1 reference

PubMed ID

18928342

19 August 2017

Farida Latif

series ordinal

3

1 reference

19 August 2017

1 October 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

10

1 reference

19 August 2017

1475-1496

1 reference

Global cancer statistics, 2002

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The developmental biology of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Focus on central nervous system neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Radiotherapy of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Gliomagenesis: genetic alterations and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Phenotype vs genotype in the evolution of astrocytic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Analysis of pilocytic astrocytoma by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Nonrandom chromosomal gains in pilocytic astrocytomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The p53MH algorithm and its application in detecting p53-responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The P53 pathway: what questions remain to be explored?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The role of p53 in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Mitogenic signaling cascades in glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Structural alterations of the epidermal growth factor receptor gene in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Recent advances in the molecular genetics of primary gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

PTEN function in normal and neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Phosphatase PTEN in neuronal injury and brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The power and the promise of DNA methylation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

DNA methylation and chromatin - unraveling the tangled web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

DNA methylation in brain development and gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

X-chromosome inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Genomic imprinting and epigenetic reprogramming: unearthing the garden of forking paths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Rett syndrome and the MECP2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The 5-methylcytosine content of DNA from human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic gene silencing in cancer: the DNA hypermethylome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

TP53 promoter methylation in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

PTEN methylation and expression in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Distinct methylation profiles of glioma subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Microsatellite instability and the PTEN1 gene mutation in a subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Long-term survival with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Genetic pathways to primary and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Human LATS1 is a mitotic exit network kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Evaluation of the 3p21.3 tumour-suppressor gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Adenoviral natural born killer gene therapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

High-resolution genome-wide mapping of genetic alterations in human glial brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Allelic status of chromosome 1 in neoplasms of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Transcriptional inactivation of TP73 expression in oligodendroglial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Gene promoter methylation in plasma and sputum increases with lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Methylation changes in faecal DNA: a marker for colorectal cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Aberrant CpG island methylation of multiple genes in ependymal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Concordant methylation of the ER and N33 genes in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation Therapy in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

Growing Y-junction carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.10.1475

10.1586/14737175.8.10.1475

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18928342